Molecular structure and antioxidant specificity of purpurogallin in three types of human cardiovascular cells

Biochemical Pharmacology

Volumn 52, Issue 7, 1996, Pages 1073-1080

  Wu, Tai Wing ^c   Zeng, Ling Hua ^a   Wu, Jun ^a   Fung, Kwok Pui ^a   Weisel, Richard D ^d   Hempel, Andrew ^b   Camerman, Norman ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d NONE

Author keywords

human cardiovascular cells; molecular properties; purpurogallin

Indexed keywords

ANTIOXIDANT; FERROUS ION; HYPOXANTHINE; MALONALDEHYDE; MENADIONE; OXYGEN RADICAL; PARAQUAT; PEROXY RADICAL; PURPUROGALLIN; PURPUROGALLIN DERIVATIVE; TETRAMETHYLPURPUROGALLIN; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CELL TYPE; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CONFORMATION; DRUG SPECIFICITY; ENDOTHELIUM CELL; ERYTHROCYTE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SAPHENOUS VEIN; X RAY CRYSTALLOGRAPHY;

EID: 0030580066     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00447-9     Document Type: Article

References (20)

1. 1. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM and Harman D, Oxygen radicals and human diseases. Ann Intern Med 107: 526-545, 1987.
2. 2. Ambrosio G and Chiariello M, Myocardial reperfusion injury: Mechanism and management - a review. Am J Med 91: 86S-88S, 1991.
3. 3. Wu TW, Wu J, Li RK, Mickle D and Carey D, Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem Cell Biol 69: 683-689, 1991.
4. 4. Wu TW, Wu J, Carey D and Zeng LH, Purpurogallin protects both ventricular myocytes and aortic endothelial cells of rats against oxyradical damage. Biochem Cell Biol 70: 803-809, 1992.
5. 5. Fung KP, Zeng LH, Wu J, Wong HNC, Lee CM, Hon PM, Chang HM, and Wu TW, Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci 52: PL239-PL244, 1993.
6. 6. Wu TW, Hashimoto N, Wu J, Carey D, Li RK, Mickle DAG and Weisel RD, The cytoprotective effect of Trolox demonstrated with three types of human cells. Biochem Cell Biol 68: 1189-1194, 1990.
7. 7. Fung KP, Wu J, Zeng LH, Wong HNC, Lee CM, Hon PM, Chang HM and Wu TW, Lithospermic acid B as an antioxidant-based protector of cultured ventricular myocytes and aortic endothelial cells of rabbit. Life Sci 53: PL189-PL193, 1993.
8. 8. Wu TW, Wu J, Zeng LH, Sugiyama H, Mickle D and Au JX, Reduction of experimental myocardial infarct size by infusion of lactosylphenyl Trolox. Cardiovasc Res 27: 736-739, 1993.
9. 9. Wu TW, Zeng LH, Fung KP, Wu J, Pang H, Grey A, Weisel RD and Wang JY, Effect of sodium tanshinone IIA sulfonate in the rabbit mycardium and on human cardiomyocytes and vascular endothelial cells. Biochem Pharmacol 46: 2327-2333, 1993.
10. 10. Anderson WA, U.S. Patent 4181545. Assigned to United Technologies Corporation, 1980.
11. 11. Prasad K, Kapoor R and Lee P, Purpurogallin, a scavenger of polymorphonuclear leukocyte-derived oxyradicals. Mol Cell Biochem 139: 27-32, 1994.
12. 12. Keyse SM and Emslie EA, Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase Nature 359: 644-647, 1992.
13. 13. Peter B, Wartena M, Kampinga HH and Konings AW, Role of lipid peroxidation and DNA damage in paraquat toxicity and the interaction of paraquat with ionizing radiation Biochem Pharmacol 43: 705-715, 1992.
14. 14. Sheldrick GM, SHELXS-86, Program for Crystal Structure Solution. University of Gottingen, Federal Republic of Germany, 1986.
15. 15. Burla MC, Camalli M, Cascarano G, Giacovazzo C, Polidori G, Spagna R and Viterbo D, SIR-88, Semi-Invariants Representation. J Appl Cryst 22: 389-393, 1989.
16. 16. Sheldrick GM, SHELXL-93, Program for the Refinement of Crystal Structure from Diffraction Data. University of Gottingen, Federal Republic of Germany, 1993.
17. 17. Miki M, Tamai H, Mino M, Yamamoto Y and Niki E, Free-radical chain oxidation of rat blood cells by molecular oxygen and its inhibition by α-tocopherol. Arch Biochem Biophys 258: 373-380, 1987.
18. 18. Afanas'ev IB, Dorozhko AI, Brodskii AV, Kostyuk VA and Potapovitch AI, Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38: 1763-1769, 1989.
19. 19. Carey D, Wu J, Sugiyama H and Wu TW, Validation of the morphologic endpoint of necrosis in rat hepatocytes subjected to oxyradical damage. Biochem Cell Biol 69: 689-694, 1991.
20. 20. Chambers DE, Parks DA, Patterson G, Roy R, McCord JM, Yoshida S, Parmley LF and Downey JM, Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 17: 145-152, 1985.